AstraZeneca’s Ultomiris Nears EU Green Light For NMOSD

After Positive CHMP Opinion

 
• By Ayisha Sharma
  
Set of traffic lights against a bright blue sky, green light illuminated
Sales Of Ultomiris Are Growing As The Soliris Franchise Declines • Source: Shutterstock

More from Rare Diseases

More from Scrip